Carter’s price target lowered to $26 from $32 at UBS

UBS lowered the firm’s price target on Carter’s (CRI) to $26 from $32 and keeps a Neutral rating on the shares. Carter’s Q2 earnings report was “disappointing,” and UBS doubts Carter’s can prove to the market it has meaningful revenue growth potential, the analyst tells investors in a research note. The firm sees meaningful downward EPS revision risk and potential for a dividend cut.